Hyaluronan tetrasaccharide in the cerebrospinal fluid is associated with self-repair of rats after chronic spinal cord compression

Neuroscience

Volumn 210, Issue , 2012, Pages 467-480

  Wang, J ^a   Rong, W ^a   Hu, X ^a   Liu, X ^a   Jiang, L ^a   Ma, Y ^a   Dang, G ^a   Liu, Z ^a   Wei, F ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

C IAP2; Caspase 3; Hyaluronan tetrasaccharide; Neurotrophic factor; NF B; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; HYALURONAN TETRASACCHARIDE; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; POLYMER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CEREBROSPINAL FLUID LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; IN VITRO STUDY; INJURY SEVERITY; LOCOMOTION; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPINAL CORD COMPRESSION; TISSUE REPAIR; UPREGULATION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CHRONIC DISEASE; ELECTROPHYSIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURONS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPINAL CORD COMPRESSION;

EID: 84861197494     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.016     Document Type: Article

References (43)

1. Al-Mefty O., Harkey H.L., Marawi I., Haines D.E., Peeler D.F., Wilner H.I., Smith R.R., Holaday H.R., Haining J.L., Russell W.F. Experimental chronic compressive cervical myelopathy. J Neurosurg 1993, 79:550-561.
2. Almond A. Hyaluronan. Cell Mol Life Sci 2007, 64:1591-1596.
3. Arbit E., Galicich W., Galicich J.H., Lau N. An animal model of epidural compression of the spinal cord. Neurosurgery 1989, 24:860-863.
4. Atkins E.D., Phelps C.F., Sheehan J.K. The conformation of the mucopolysa ccharides. Hyaluronates. Biochem J 1972, 128:1255-1263.
5. Baptiste D.C., Fehlings M.G. Pathophysiology of cervical myelopathy. Spine J 2006, 49:190S-197S.
6. Bednarik J., Kadanka Z., Dusek L., Novotny O., Surelova D., Urbanek I., Prokes B. Presymptomatic spondylotic cervical cord compression. Spine (Phila Pa 1976) 2004, 29:2260-2269.
7. Bednarik J., Kadanka Z., Dusek L., Kerkovsky M., Vohanka S., Novotny O., Urbanek I., Kratochvilova D. Presymptomatic spondylotic cervical myelopathy: an updated predictive model. Eur Spine J 2008, 17:421-431.
8. Bracken M.B., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M.G., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot P.L., Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998, 89:699-706.
9. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochem Pharmacol 2010, 80:480-490.
10. Cheung M.M., Li D.T., Hui E.S., Fan S., Ding A.Y., Hu Y., Wu E.X. In vivo diffusion tensor imaging of chronic spinal cord compression in rat model. Conf Proc IEEE Eng Med Biol Soc 2009, 6:2715-2718.
11. Delattre J.Y., Arbit E., Thaler H.T., Rosenblum M.K., Posner J.B. A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J Neurosurg 1989, 70:920-925.
12. Grimm S., Bauer M.K., Baeuerle P.A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol 1996, 134:13-23.
13. Han X., Yang N., Xu Y., Zhu J., Chen Z., Liu Z., Dang G., Song C. Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF. Neurosci Lett 2011, 487:255-259.
14. Harkey H.L., Al-Mefty O., Marawi I., Peeler D.F., Haines D.E., Alexander L.F. Experimental chronic compressive cervical myelopathy: effects of decompression. J Neurosurg 1995, 83:336-341.
15. Horton M.R., McKee C.M., Bao C., Liao F., Farber J.M., Hodge-DuFour J., Pure E., Oliver B.L., Wright T.M., Noble P.W. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998, 273:35088-35094.
16. Horton M.R., Shapiro S., Bao C., Lowenstein C.J., Noble P.W. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 1999, 162:4171-4176.
17. Hu Y., Wen C.Y., Li T.H., Cheung M.M., Wu E.X., Luk K.D. Somatosensory-evoked potentials as an indicator for the extent of ultrastructural damage of the spinal cord after chronic compressive injuries in a rat model. Clin Neurophysiol 2011, 122:1440-1447.
18. Inukai T., Uchida K., Nakajima H., Yayama T., Kobayashi S., Mwaka E.S., Guerrero A.R., Baba H. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression. Spine (Phila Pa 1976) 2009, 34:2848-2857.
19. Kasahara K., Nakagawa T., Kubota T. Neuronal loss and expression of neurotrophic factors in a model of rat chronic compressive spinal cord injury. Spine (Phila Pa 1976) 2006, 31:2059-2066.
20. Kim G., Xu J., Xu J., Song S.K., Yan P., Ku G., Xu X.M., Hsu C.Y. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 2001, 17:6617-6625.
21. Kim P., Haisa T., Kawamoto T., Kirino T., Wakai S. Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann Neurol 2004, 55:503-511.
22. LeBlanc A.C. Natural cellular inhibitors of caspases. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:215-229.
23. Lees V.C., Fan T.P., West D.C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 1995, 73:259-266.
24. Manabe S., Tanaka H., Higo Y., Park P., Ohno T., Tateishi A. Experimental analysis of the spinal cord compressed by spinal metastasis. Spine (Phila Pa 1976) 1989, 14:1308-1315.
25. Matsumoto M., Fujimura Y., Suzuki N., Nishi Y., Nakamura M., Yabe Y., Shiga H. MRI of cervical intervertebral discs in asymptomatic subjects. J Bone Joint Surg Br 1998, 80:19-24.
26. Meyer K., Palmer J. The polysaccharide of the vitreous humor. J Biol Chem 1934, 107:629-634.
27. Ning B., Zhang A., Song H., Gong W., Ding Y., Guo S. Recombinant human erythropoietin prevents motor neuron apoptosis in a rat model of cervical sub-acute spinal cord compression. Neurosci Lett 2011, 490:57-62.
28. Park J.P., Kim K.J., Phi J.H., Park C.K., Kim J.H., Kang H.J., Lee D., Han K.H., Wang K.C., Paek S.H. Simple measurement of spinal cord evoked potential: a valuable data source in the rat spinal cord injury model. J Clin Neurosci 2007, 14:1099-1105.
29. Rivlin A.S., Tator C.H. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977, 47:577-581.
30. Sakayama K., Kidani T., Sugawara Y., Masuno H., Matsuda Y., Yamamoto H. Elevated concentration of hyaluronan in the cerebrospinal fluid is a secondary marker of spinal disorders: hyaluronan in the cerebrospinal fluid in patients with spinal disorders. J Spinal Disord Tech 2006, 19:262-265.
31. Sherman L.S., Struve J.N., Rangwala R., Wallingford N.M., Tuohy T.M., Kuntz C. Hyaluronate-based extracellular matrix: keeping glia in their place. Glia 2002, 38:93-102. Th.
32. Silva R.F., Falcão A.S., Fernandes A., Gordo A.C., Brito M.A., Brites D. Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicol Lett 2006, 163:1-9.
33. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85:699-715.
34. Struve J., Maher P.C., Li Y.Q., Kinney S., Fehlings M.G., Kuntz C., Sherman L.S. Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. Glia 2005, 52:16-24. Th.
35. Takenouchi T., Setoguchi T., Yone K., Komiya S. Expression of apoptosis signal-regulating kinase 1 in mouse spinal cord under chronic mechanical compression: possible involvement of the stress-activated mitogen-activated protein kinase pathways in spinal cord cell apoptosis. Spine (Phila Pa 1976) 2008, 33:1943-1950.
36. Torigoe K., Tanaka H.F., Ohkochi H., Miyasaka M., Yamanokuchi H., Yoshidad K., Yoshida T. Hyaluronan tetrasaccharide promotes regeneration of peripheral nerve: in vivo analysis by film model method. Brain Res 2011, 1385:87-92.
37. Uchida K., Nakajima H., Inukai T., Takamura T., Kobayashi S., Furukawa S., Baba H. Adenovirus-mediated retrograde transfer of neurotrophin-3 gene enhances survival of anterior horn neurons of twy/twy mice with chronic mechanical compression of the spinal cord. J Neurosci Res 2008, 86:1789-1800.
38. Wakao N., Imagama S., Zhang H., Tauchi R., Muramoto A., Natori T., Takeshita S., Ishiguro N., Matsuyama Y., Kadomatsu K. Hyaluronan oligosaccharides promote functional recovery after spinal cord injury in rats. Neurosci Lett 2011, 12:1-6.
39. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
40. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
41. Wolf D., Schümann J., Koerber K., Kiemer A.K., Vollmar A.M., Sass G., Papadopoulos T., Bang R., Klein S.D., Brune B., Tiegs G. Low-molecular-weight hyaluronic acid induces nuclear factor-kappaB-dependent resistance against tumor necrosis factor alpha-mediated liver injury in mice. Hepatology 2001, 34:535-547.
42. Yamaura I., Yone K., Nakahara S., Nagamine T., Baba H., Uchida K., Komiya S. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine (Phila Pa 1976) 2002, 27:21-26.
43. Yu W.R., Baptiste D.C., Liu T., Odrobina E., Stanisz G.J., Fehlings M.G. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol Dis 2009, 33:149-163.